Literature DB >> 10508241

Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual.

J L Torán1, L Kremer, L Sánchez-Pulido, I M de Alborán, G del Real, M Llorente, A Valencia, M A de Mon, C Martínez-A.   

Abstract

To characterize the variable heavy chain (VH)3 antibody response to HIV-1 gp120, we analyzed a panel of IgM and IgG1 Fab fragments from phage display isotype libraries from a long-term, non-progressor HIV-1-infected individual. The IgM Fab antibodies isolated had low affinity for gp120, were not restricted to a particular VH3 germ-line gene, and consisted mainly of unmutated VH genes. In contrast, IgG Fab fragments were gp120 specific, with high affinity and extensive somatic mutation; all were clonally related and were derived from a single VH3 germ-line gene (DP50). One IgG Fab (S8) has DP50 VH region nucleotide substitutions identical to those of IgM Fab M025 and uses similar DH and JH segments, suggesting that S8 arose from M025 by isotype switching. In addition, somatic mutation in the IgG heavy chain third complementarity-determining region results in a 100-fold affinity increase for gp120, which correlates with a similar increase in neutralization capacity. These results imply that in vivo IgM to IgG isotype switch and affinity maturation may be important for protection and long-term survival in certain HIV-1-infected individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508241     DOI: 10.1002/(SICI)1521-4141(199909)29:09<2666::AID-IMMU2666>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  The Antibody Response against HIV-1.

Authors:  Julie Overbaugh; Lynn Morris
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

2.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

3.  Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.

Authors:  Amandeep K Dhillon; Helen Donners; Ralph Pantophlet; Welkin E Johnson; Julie M Decker; George M Shaw; Fang-Hua Lee; Douglas D Richman; Robert W Doms; Guido Vanham; Dennis R Burton
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Authors:  Elin S Gray; Maphuti C Madiga; Tandile Hermanus; Penny L Moore; Constantinos Kurt Wibmer; Nancy L Tumba; Lise Werner; Koleka Mlisana; Sengeziwe Sibeko; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

5.  Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.

Authors:  Alexander D Douglas; Simone C de Cassan; Matthew D J Dicks; Sarah C Gilbert; Adrian V S Hill; Simon J Draper
Journal:  Vaccine       Date:  2010-10-18       Impact factor: 3.641

Review 6.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

7.  Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins.

Authors:  Weizao Chen; Zhongyu Zhu; Huaxin Liao; Gerald V Quinnan; Christopher C Broder; Barton F Haynes; Dimiter S Dimitrov
Journal:  Viruses       Date:  2010-02       Impact factor: 5.048

Review 8.  Neutralization-Enhancing RF Antibodies for HIV Vaccines.

Authors:  Konstantin V Suslov
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

9.  IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus.

Authors:  Li Yin; Wei Hou; Li Liu; Yunpeng Cai; Mark Andrew Wallet; Brent Paul Gardner; Kaifen Chang; Amanda Catherine Lowe; Carina Adriana Rodriguez; Panida Sriaroon; William George Farmerie; John William Sleasman; Maureen Michels Goodenow
Journal:  Front Immunol       Date:  2013-11-15       Impact factor: 7.561

Review 10.  Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities.

Authors:  Anna Timofeeva; Sergey Sedykh; Georgy Nevinsky
Journal:  Vaccines (Basel)       Date:  2022-03-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.